Publications
View AllLenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
Lenvatinib plus pembrolizumab was associated with significantly longer progression-free survival and overall survival than sunitinib. (Funded by Eisai and Merck Sharp and Dohme;...
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
Maintenance avelumab plus best supportive care significantly prolonged overall survival, as compared with best supportive care alone, among patients with urothelial cancer who h...
Affiliated Researchers
Institution Info
- Type
- government
- Country
- RU
- Publications
- 3
- Citations
- 10,020
External Links
Identifiers
- ROR
- https://ror.org/05j351806